Exercise timing for people with prediabetes and overweight/obesity
Official title: Timed Exercise in Prediabetes With Extreme Chronotype
Run by German Diabetes Center · NCT07389005 · Data updated 2026-11-12
This study tests whether doing a single exercise session in the morning or in the evening helps control blood sugar better in adults with prediabetes who are overweight or obese.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 19 Years to 75 Years |
| Sex | All |
| Enrollment | 28 (estimated) |
| Sponsor | German Diabetes Center Academic / other |
| Locations | 1 site (Düsseldorf) |
| Status | Recruiting |
| Started | September 2026 |
| Main results expected | August 2028 |
| Study ends | August 2028 |
| Registry record updated | September 11, 2026 |
| Trial ID | NCT07389005 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults 18–75 with BMI 25–35 kg/m2 who have prediabetes and a morning or evening chronotype measured by MEQ scores.
✕Probably not a fit
Individuals not showing glucose response differences by time of exercise or those outside chronotype criteria may see minimal benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
Participants with prediabetes who are overweight or mildly obese will try three conditions on different days: no exercise, morning exercise, and evening exercise, with at least 14 days between days. Morning exercise will occur at 9:00 am and involve intervals of hard effort followed by short rests; the evening session timing is designed to align with chronotype. The order of conditions is randomized, and safety and metabolic responses will be monitored in a research setting. The goal is to see if aligning exercise timing with a person’s chronotype improves glucose handling. This study uses a crossover design to compare each participant across the three conditions.
Why it matters
Potential benefit: If successful, timing exercise to a person’s clock could improve blood sugar control for people at risk of diabetes.
How similar studies have gone: Prior research suggests timing of exercise can influence glucose control in at-risk populations, but results vary and this crossover study adds chronotype considerations.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Able to provide signed and dated written informed consent prior to any study specific procedures 2. Adult men and women aged between more than 18 and ≤ 75 years 3. Body mass index (BMI) of 25 - 35 kg/m2 4. Stable weight (no weight loss or gain \> 3 kg in the past 3 months) 5. Pre-diabetes defined as an isolated impaired glucose tolerance or a combination of impaired glucose tolerance and impaired fasting glucose (values are based on the American Diabetes Association (ADA): 1. impaired glucose tolerance (plasma glucose 140 mg/dL to 199 mg/dL, 120 minutes after consumption of 75g of glucose) 2. impaired fasting glucose (fasting plasma glucose 100 mg/dL to 125 mg/dL) 6. Morning (Morningness-Eveningness Questionnaire \[MEQ\] score ≥ 59) or evening (MEQ score ≤ 41) chronotype Exclusion Criteria: 1. Previously diagnosed with type 2 diabetes 2. Moderate to severe anemia (hemoglobin \< 10 g/L) 3. Uncontrolled hypertension 4. Abnormal electrocardiogram (ECG) at rest judged by the study physician 5. Pregnancy or breastfeeding 6. HIV, hepatitis B, or C infection 7. Disorders of blood clotting or wound healing 8. Positive history of venous thrombosis (contraindication for clamp) 9. Hypersensitivity to local anesthetics (contraindication for fat/muscle biopsies) 10. Night shift work in the last 3 months 11. Travel across \> 1 time zone in the last 3 months 12. Participation in another clinical trials that may possibly hamper the study results 13. Engagement in structured exercise activities \> 2 hours a week 14. Any acute condition, exacerbation of chronic condition, or medical history that in the investigator's opinion would interfere with the study 15. Any contraindication for MRI scanning 16. Medication use known to hamper safety during the study procedures 17. Non-German speaking
Where it's running
-
German Diabetes Center (DDZ)
Düsseldorf, Germany Recruiting
Study contacts
- Principal investigator: Patrick Schrauwen, PhD — German Diabetes Center
- Study coordinator: Patrick Schrauwen, PhD
- Email: patrick.schrauwen@ddz.de
- Phone: +49 211 3382-689
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Smartwatch-based program to improve heart health in adults with overweight and cardiometabolic risk
This project will test whether a smartwatch-led exercise, diet, and coaching program can help adults who are overweight or obese with prehypertension, prediabetes, or borderline high cholesterol improve their cardiovascular health.
-
Semaglutide on body composition in adults with type 1 diabetes and overweight/obesity
This study tests whether weekly semaglutide changes body composition in adults with type 1 diabetes who are overweight or obese, compared with a placebo over 24 weeks.
-
Lifestyle Metabotype Study B: Understanding Personalized Glucose Responses
This study tests how lifestyle, metabolism, and brain energy use relate to each person’s blood sugar response after meals, across people with and without prediabetes or type 2 diabetes.
-
UBT37034 Injection safety study in adults with overweight or obesity
This study tests different doses of UBT37034 injections to see if they are safe and tolerable in adults who are overweight or have obesity.
-
Lifestyle Metabotype Study: How Daily Habits Shape Blood Sugar
This observational study tests whether personal lifestyle and biological factors can predict how a person’s blood sugar responds after meals.
-
Two-Week Stair-Climbing “Exercise Snacks” to Test Metabolic Health
In adults with overweight or obesity who don’t exercise regularly, a two-week program of short stair climbs throughout the day will be tested to see if it improves metabolic health and fitness.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.